Taiwan · Delayed Price · Currency is TWD Puriblood Medical Statistics
Total Valuation
TPEX:6847 has a market cap or net worth of TWD 1.11 billion. The enterprise value is 1.11 billion.
| Market Cap | 1.11B |
| Enterprise Value | 1.11B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6847 has 14.23 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 14.23M |
| Shares Outstanding | 14.23M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 22.38% |
| Owned by Institutions (%) | 6.62% |
| Float | 6.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.75 |
| PB Ratio | 10.12 |
| P/TBV Ratio | 10.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.70, with a Debt / Equity ratio of 0.35.
| Current Ratio | 1.70 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.18 |
| Interest Coverage | -35.18 |
Financial Efficiency
Return on equity (ROE) is -40.92% and return on invested capital (ROIC) is -43.95%.
| Return on Equity (ROE) | -40.92% |
| Return on Assets (ROA) | -12.97% |
| Return on Invested Capital (ROIC) | -43.95% |
| Return on Capital Employed (ROCE) | -33.23% |
| Weighted Average Cost of Capital (WACC) | 4.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 38 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 1.73 |
Taxes
In the past 12 months, TPEX:6847 has paid 1.42 million in taxes.
| Income Tax | 1.42M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.60% in the last 52 weeks. The beta is 0.13, so TPEX:6847's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | +3.60% |
| 50-Day Moving Average | 76.94 |
| 200-Day Moving Average | 71.25 |
| Relative Strength Index (RSI) | 52.00 |
| Average Volume (20 Days) | 34,614 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6847 had revenue of TWD 80.54 million and -55.81 million in losses. Loss per share was -3.92.
| Revenue | 80.54M |
| Gross Profit | 17.88M |
| Operating Income | -47.57M |
| Pretax Income | -54.40M |
| Net Income | -55.81M |
| EBITDA | -41.59M |
| EBIT | -47.57M |
| Loss Per Share | -3.92 |
Balance Sheet
The company has 39.78 million in cash and 38.64 million in debt, with a net cash position of 1.14 million or 0.08 per share.
| Cash & Cash Equivalents | 39.78M |
| Total Debt | 38.64M |
| Net Cash | 1.14M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 109.39M |
| Book Value Per Share | 7.68 |
| Working Capital | 42.90M |
Cash Flow
In the last 12 months, operating cash flow was -32.27 million and capital expenditures -386,000, giving a free cash flow of -32.66 million.
| Operating Cash Flow | -32.27M |
| Capital Expenditures | -386,000 |
| Depreciation & Amortization | 5.98M |
| Net Borrowing | -8.32M |
| Free Cash Flow | -32.66M |
| FCF Per Share | -2.30 |
Margins
Gross margin is 22.20%, with operating and profit margins of -59.06% and -69.30%.
| Gross Margin | 22.20% |
| Operating Margin | -59.06% |
| Pretax Margin | -67.54% |
| Profit Margin | -69.30% |
| EBITDA Margin | -51.64% |
| EBIT Margin | -59.06% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6847 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
| Earnings Yield | -5.04% |
| FCF Yield | -2.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |